Omeprazole Patent Expiration
Omeprazole was first introduced by Astrazeneca Pharmaceuticals Lp
Omeprazole Patents
Given below is the list of patents protecting Omeprazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Omeprazole | US10076494 | Stable orally disintegrating pharmaceutical compositions | Dec 08, 2036 | Dexcel |
| Omeprazole | US10835488 | Stable orally disintegrating pharmaceutical compositions | Dec 08, 2036 | Dexcel |
| Omeprazole | US9023391 | Stable benzimidazole formulation | Aug 16, 2025 | Dexcel Pharma |
| Prilosec |
US6150380 (Pediatric) | Crystalline form of omeprazole |
May 10, 2019
(Expired) | Astrazeneca |
| Prilosec |
US6147103 (Pediatric) | Omeprazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Prilosec |
US6166213 (Pediatric) | Omeprazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Prilosec |
US6191148 (Pediatric) | Omerazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Prilosec | US6150380 | Crystalline form of omeprazole |
Nov 10, 2018
(Expired) | Astrazeneca |
| Prilosec | US6147103 | Omeprazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
| Prilosec | US6166213 | Omeprazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
| Prilosec | US6191148 | Omerazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Omeprazole's patents.
Latest Legal Activities on Omeprazole's Patents
Given below is the list recent legal activities going on the following patents of Omeprazole.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 May, 2024 | US10835488 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Oct, 2022 | US9023391(Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2022 | US10076494 |
| Recordation of Patent Grant Mailed Critical
| 17 Nov, 2020 | US10835488 |
| Patent Issue Date Used in PTA Calculation Critical
| 17 Nov, 2020 | US10835488 |
| Email Notification Critical
| 29 Oct, 2020 | US10835488 |
| Issue Notification Mailed Critical
| 28 Oct, 2020 | US10835488 |
| Email Notification Critical
| 13 Oct, 2020 | US10835488 |
| Mailing Corrected Notice of Allowability | 13 Oct, 2020 | US10835488 |
| Dispatch to FDC | 10 Oct, 2020 | US10835488 |
Omeprazole's Family Patents
